Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Vietnam Vaccine Consortium (VVC) is a strategic joint venture established in 2021 by major Vietnamese conglomerates, including Vingroup, the Vietnam Vaccine Joint Stock Company (VNVC), and T&T Group, to enhance the nation's vaccine production and procurement capabilities. Formed in response to the COVID-19 pandemic, the consortium focuses on technology transfer, large-scale manufacturing, and the distribution of advanced vaccines and biological products. VVC has partnered with international entities such as Arcturus Therapeutics and the Russian Direct Investment Fund (RDIF) to produce mRNA and viral vector vaccines domestically. The consortium plays a pivotal role in Vietnam's healthcare infrastructure by ensuring a stable supply of critical immunizations and fostering local expertise in biotechnology manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vietnam consortium manufacturers.